Global Down Syndrome

Summer 2018

Issue link: https://viewer.e-digitaledition.com/i/1038839

Contents of this Issue

Navigation

Page 10 of 31

Topics of emphasis may include chromosome silencing, immune system dysregulation, epigenetic/metabolomic/ transcriptomic profiling in model organisms/iPSCs (induced pluripotent stem cells)/brain organoids, development of novel model systems, and development of a molecular atlas for cardiac and other specimens. • Component 2: Cohort study to connect existing resources and expand to inclusion of individuals with Down syndrome A large cohort of individuals with Down syndrome is essential to follow individuals' development over time and perform deep phenotyping and natural history studies. INCLUDE will develop a comprehensive genomic, epigenomic, transcriptomic, and proteomic map to help understand the predisposing risk and protective factors that underlie the highly penetrant features in Down syndrome. Enrolling a cross-sectional cohort of individuals with Down syndrome at different ages across the lifespan will capture the broadest array of phenotypes and ages of onset for the co-existing conditions, as well as the critical windows for interventions. • Component 3: Clinical trials network to create a "medical home" for individuals with Down syndrome and encourage their inclusion into ongoing clinical research ... Very few, if any, clinical studies have examined differences in how commonly used medications affect people with Down syndrome. The extremely limited number of medication trials to date in humans with Down syndrome (11 worldwide) have primarily focused on improving cognition, memory, and adaptive functioning. There has been a remarkable lack of success in these clinical trials. Establishment of a clinical trials network would focus on repurposing existing therapies as well as developing new ones … These efforts will target quality-of-life challenges that individuals with Down syndrome and their families confront across the lifespan. PROPOSED FISCAL YEAR 2018 BUDGET FOR INCLUDE We plan to invest $21 million in FY2018 to lay critical groundwork and engage the scientific community … to jump-start this effort while setting the stage for FY2019 and beyond. Specifically, we will solicit administrative supplement applications via two notices: • Notice for existing studies in Down syndrome that can be supplemented to address a targeted area of emphasis, expand the sample size, address a related issue of relevance for Down syndrome research, or create an expanded resource or cohort that will pave the way for future cohorts and clinical trials • Notice to amend or augment existing projects that are not focused on Down syndrome by adding a cohort or aim that includes a Down syndrome component. FUTURE DIRECTIONS: FY2019–FY2022 Following initial investments in FY2018 to build capacity and further plan for INCLUDE in consultation with stakeholders, we plan to ramp up to $60 million in FY2019 to fully launch the INCLUDE project, pending available funding. This support will continue FY2018 out-year commitments/ongoing obligations and also support additional supplements in FY2019 to further leverage existing infrastructure. In FY2019, we will also transition the funding stream to one driven by new requests for applications to the greatest extent possible. We anticipate that this level of support will be maintained in FY2020 through FY2022, as this effort is fully underway, supporting the out-years of the main components. CONCLUSION Through INCLUDE, we aim to support the most promising high risk–high reward basic science. In addition, development and maintenance of a data and sample repository will serve the scientific community … for decades to come. Individuals with Down syndrome will be encouraged to participate in ongoing clinical research studies, while a clinical trial network and "medical home" will be created for individuals with Down syndrome and their families to ensure full inclusion into promising clinical research as novel therapies emerge in the future. We welcome the opportunity to embark on this initiative in partnership with the Down syndrome community to improve the health and quality of life of individuals with Down syndrome and all individuals who are impacted by many of these co- occurring conditions. To read the INCLUDE project in its entirety, visit nih.gov/include- project/include-project-research-plan. GLOBALDOWNSYNDROME.ORG 11

Articles in this issue

Links on this page

Archives of this issue

view archives of Global Down Syndrome - Summer 2018